Skip to main content
logo
Sotera Health Company (MUN:SH5)
Germany flag Germany · Delayed Price · Currency is EUR
14.80
0.00 (0.00%)
At close: Feb 20, 2026

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2019
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18
United States Revenue
-616.68M590.97M
United States Revenue Growth
-4.35%2.06%
Canada Revenue
-208.89M192.05M
Canada Revenue Growth
-8.77%1.75%
Europe Revenue
-196.01M187.54M
Europe Revenue Growth
-4.52%12.96%
Other Geographic Revenue
-78.86M78.73M
Other Geographic Revenue Growth
-0.17%12.63%
Revenue (Total)
1.15B1.10B1.05B
Revenue (Total) Growth
4.54%4.88%4.54%

Revenue Breakdown

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2019
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18
Sterigenics Revenue
736.80M697.85M667.13M
Sterigenics Revenue Growth
5.58%4.61%6.46%
Nordion Revenue
194.58M173.36M160.46M
Nordion Revenue Growth
12.25%8.04%4.44%
Nelson Labs Revenue
219.00M229.23M221.70M
Nelson Labs Revenue Growth
-4.46%3.40%-0.76%
Revenue (Total)
1.15B1.10B1.05B
Revenue (Total) Growth
4.54%4.88%4.54%

Revenue Breakdown 2

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2019
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18
Service Revenue
975.51M941.82M905.60M
Service Revenue Growth
3.58%4.00%4.71%
Product Revenue
174.87M158.62M143.69M
Product Revenue Growth
10.25%10.39%3.48%
Revenue (Total)
1.15B1.10B1.05B
Revenue (Total) Growth
4.54%4.88%4.54%

Adjusted EBITDA

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2019
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18
Sterigenics Segment Income
402.49M378.17M362.21M
Sterigenics Segment Income Growth
6.43%4.41%6.80%
Nordion Segment Income
114.23M101.22M96.68M
Nordion Segment Income Growth
12.85%4.70%8.05%
Nelson Labs Segment Income
72.98M69.18M69.14M
Nelson Labs Segment Income Growth
5.49%0.06%-10.94%
Operating Income (Other)
-245.90M-250.95M-251.34M
Operating Income (Total)
343.80M297.63M276.69M
Operating Income (Total) Growth
15.51%7.57%11.41%

Capital Expenditures

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2019
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18
Sterigenics Capital Expenditures
112.15M131.26M163.04M
Sterigenics Capital Expenditures Growth
-14.56%-19.50%13.20%
Nordion Capital Expenditures
26.75M34.93M38.35M
Nordion Capital Expenditures Growth
-23.41%-8.92%44.31%
Nelson Labs Capital Expenditures
14.28M12.88M13.58M
Nelson Labs Capital Expenditures Growth
10.85%-5.13%15.33%
Updated Sep 30, 2025. Data Source: Fiscal.ai.